Concepedia

Paula J. Alvarez

PJ

8

Publications

299

Citations

8

H-Index

2016

Active since

Affiliations

Vifor Pharma (United States)(Current)

CVS Health (United States)

Aetna (United States)

Paula J. Alvarez is an author at Vifor Pharma (United States) specializing in pharmacotherapy, cardiovascular pharmacology, and hypertension.

ORCID

Top concepts

Publications per year

2016–2022

8

Publications

8

All-cause costs increase exponentially with increased chronic kidney disease stage.

Ladan Golestaneh, Paula J. Alvarez, Nancy L. Reaven et al. · PubMed · 2017 · 137 citations

Clinical and Economic Impact of Hyperkalemia in Patients with Chronic Kidney Disease and Heart Failure

Michael Polson, Todd Lord, Anne Kangethe et al. · Journal of Managed Care & Specialty Pharmacy · 2017 · 56 citations · Full text

Evaluation of clinical outcomes and costs based on prescribed dose level of renin-angiotensin-aldosterone system inhibitors.

Murray Epstein, Paula J. Alvarez, Nancy L. Reaven et al. · PubMed · 2016 · 26 citations

, , +11

Hyperkalemia treatment modalities: A descriptive observational study focused on medication and healthcare resource utilization

Nihar R. Desai, Christopher G. Rowan, Paula J. Alvarez et al. · PLoS ONE · 2020 · 20 citations · Full text

Healthcare resource utilization and costs associated with hyperkalemia in a large managed care population

Ajay Sharma, Paula J. Alvarez, Steven D. Woods et al. · Journal of Pharmaceutical Health Services Research · 2021 · 17 citations · Full text

, , +28

Rows per page

1–5 of 8